SE0402268L - Tidig barndomsinfektion med humant herpes virus typ 6 (HHV-6) som ett skydd mot utvecklingen av atopisk sjukdom och allergi hos unga barn - Google Patents
Tidig barndomsinfektion med humant herpes virus typ 6 (HHV-6) som ett skydd mot utvecklingen av atopisk sjukdom och allergi hos unga barnInfo
- Publication number
- SE0402268L SE0402268L SE0402268A SE0402268A SE0402268L SE 0402268 L SE0402268 L SE 0402268L SE 0402268 A SE0402268 A SE 0402268A SE 0402268 A SE0402268 A SE 0402268A SE 0402268 L SE0402268 L SE 0402268L
- Authority
- SE
- Sweden
- Prior art keywords
- hhv
- allergies
- development
- protection against
- virus type
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
- A61K35/763—Herpes virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16511—Roseolovirus, e.g. human herpesvirus 6, 7
- C12N2710/16533—Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0402268A SE528319C2 (sv) | 2004-09-17 | 2004-09-17 | Användning av humant herpesvirus 6 eller derivat av dessa för tillverkning av en farmaceutisk komposition för förebyggandet av atopi eller atopisk sjukdom, inklusive astma, hos barn |
CA002580717A CA2580717A1 (en) | 2004-09-17 | 2005-09-16 | Early childhood infection with human herpes virus type 6 (hhv-6) as a protection against the development of ige sensitization, atopic disease and allergy in young children. |
EP05784509A EP1796699A1 (en) | 2004-09-17 | 2005-09-16 | Early childhood infection with human herpes virus type 6 (hhv-6) as a protection against the development of ige sensitization, atopic disease and allergy in young children. |
PCT/SE2005/001357 WO2006031195A1 (en) | 2004-09-17 | 2005-09-16 | Early childhood infection with human herpes virus type 6 (hhv-6) as a protection against the development of ige sensitization, atopic disease and allergy in young children. |
US11/687,853 US20070207169A1 (en) | 2004-09-17 | 2007-03-19 | Early childhood infection with human herpes virus type 6 (hhv-6) as a protection against the development of ige sensitization, atopic disease and allergy in young children |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0402268A SE528319C2 (sv) | 2004-09-17 | 2004-09-17 | Användning av humant herpesvirus 6 eller derivat av dessa för tillverkning av en farmaceutisk komposition för förebyggandet av atopi eller atopisk sjukdom, inklusive astma, hos barn |
Publications (3)
Publication Number | Publication Date |
---|---|
SE0402268D0 SE0402268D0 (sv) | 2004-09-17 |
SE0402268L true SE0402268L (sv) | 2006-03-18 |
SE528319C2 SE528319C2 (sv) | 2006-10-17 |
Family
ID=33308780
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0402268A SE528319C2 (sv) | 2004-09-17 | 2004-09-17 | Användning av humant herpesvirus 6 eller derivat av dessa för tillverkning av en farmaceutisk komposition för förebyggandet av atopi eller atopisk sjukdom, inklusive astma, hos barn |
Country Status (5)
Country | Link |
---|---|
US (1) | US20070207169A1 (sv) |
EP (1) | EP1796699A1 (sv) |
CA (1) | CA2580717A1 (sv) |
SE (1) | SE528319C2 (sv) |
WO (1) | WO2006031195A1 (sv) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI20075063A0 (sv) | 2007-02-01 | 2007-02-01 | Vactech Oy | Prevention av allergisk sensibilisering |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0524421B1 (en) * | 1991-07-08 | 2003-03-26 | Dade Behring Marburg GmbH | Human herpesvirus type 6 protein p100, the corresponding DNA sequences, their preparation and use |
US5716623A (en) * | 1994-12-07 | 1998-02-10 | Immunex Corporation | Isolated Herpesvirus saimiri proteins that bind MHC Class II molecules |
EP1383536B1 (en) * | 2001-03-28 | 2012-08-08 | THE GOVERNMENT OF THE UNITED STATES, As represented by THE SECRETARY OF HEALTH AND HUMAN SERVICES, NATIONAL INSTITUTES OF HEALTH | Use of herpesviruses to inhibit ccr5-tropic hiv-1 infection and replication |
-
2004
- 2004-09-17 SE SE0402268A patent/SE528319C2/sv not_active IP Right Cessation
-
2005
- 2005-09-16 WO PCT/SE2005/001357 patent/WO2006031195A1/en active Application Filing
- 2005-09-16 EP EP05784509A patent/EP1796699A1/en not_active Withdrawn
- 2005-09-16 CA CA002580717A patent/CA2580717A1/en not_active Abandoned
-
2007
- 2007-03-19 US US11/687,853 patent/US20070207169A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2580717A1 (en) | 2006-03-23 |
SE0402268D0 (sv) | 2004-09-17 |
EP1796699A1 (en) | 2007-06-20 |
US20070207169A1 (en) | 2007-09-06 |
SE528319C2 (sv) | 2006-10-17 |
WO2006031195A1 (en) | 2006-03-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY2018025I2 (el) | Εμβολιο ιου ερπητα ζωστηρα | |
DE60316323D1 (de) | Feste pharmazeutische formulierungen mit telmisartan | |
NO20033272L (no) | Et virus som forårsaker sykdom i luftveiene i mottakelige pattedyr | |
DE602005025438D1 (de) | Staubsauger mit Zyklon-Filter | |
NO20085420L (no) | Farmasøytisk formulering med fenylefrin og preparater for absorpsjon i tykktarmen | |
ATE472534T1 (de) | Benzimidazolderivate: herstellung und pharmazeutische anwendungen | |
FR2885139B1 (fr) | Preparation de complexes solubles proteine n-proteine p tronquee ou de proteine n soluble d'un virus de la famille des paramyxoviridae et leurs utilisations vaccinales | |
DE60304993D1 (de) | In der mundhöhle dispergierbare pharmazeutische zusammensetzung mit agomelatin | |
FR2863607B1 (fr) | Vitroceramiques a surface modifiee et leur preparation | |
DE602005021475D1 (de) | Magenresistente pharmazeutische dosierform mit n-(2-(2-phthalimidoethoxy)-acetyl)-l-alanyl-d-glutaminsäure (lk-423) | |
EP1765330A4 (en) | PYRANOINDOLE DERIVATIVES AND USE THEREOF FOR THE TREATMENT OF DISEASE OR INFECTION CAUSED BY HEPATITIS C VIRUS | |
DK1694694T3 (da) | Replikationskompetent hepatitis C-virus samt anvendelsesfremgangsmåder | |
DE60305728D1 (de) | PHARMAZEUTISCHE ZUSAMMENSETZUNG MIT VERLuNGERTER FREISETZUNG | |
FR2823222B1 (fr) | Vaccin contre le virus de la fievre du nil | |
EP1552021A4 (en) | INTERFERON TYPE I INDUCIBLE PROTEINS FOR THE DETECTION OF VIRUS INFECTION | |
SE0402268L (sv) | Tidig barndomsinfektion med humant herpes virus typ 6 (HHV-6) som ett skydd mot utvecklingen av atopisk sjukdom och allergi hos unga barn | |
SE0601947L (sv) | Lagringsstabila polymer-oligomer-partiklar och deras användning vid svällningspolymerisation | |
DK1973931T3 (da) | Hønsevirusvaccine og -diagnosticering | |
DE602006010337D1 (de) | 1,2,4-triazinderivate, ihre herstellung und ihre verwendung in der humantherapie | |
AU2003243663A8 (en) | Vaccines for suppressing ige-mediated allergic disease and methods for using the same | |
DE602004020063D1 (de) | Pyrido[2,3-d] pyrimidin-7-carbonsäurederivate, deren herstellung und deren verwendung als pharmazeutische mittel | |
DE602006008971D1 (de) | N-ä(4,5-diphenylpyrimidin-2-yl)methylüaminderivate, deren herstellung und deren therapeutische verwendung | |
DK1945797T3 (da) | Hepatitis C-virus NS2/3-aktivitetsanalyse | |
DE602005001505D1 (de) | Etherderivate, deren herstellung und deren verwendung als pharmazeutische mittel | |
DE602005005033D1 (de) | Sprühgetrocknete pharmazeutische zusammensetzungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NUG | Patent has lapsed |